241 related articles for article (PubMed ID: 26928923)
1. Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis.
Scheuern A; Fischer N; McDonald J; Brunner HI; Haas JP; Hügle B
Pediatr Rheumatol Online J; 2016 Feb; 14(1):11. PubMed ID: 26928923
[TBL] [Abstract][Full Text] [Related]
2. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.
Zajc Avramovič M; Dolžan V; Toplak N; Accetto M; Lusa L; Avčin T
J Rheumatol; 2017 Aug; 44(8):1216-1223. PubMed ID: 28572465
[TBL] [Abstract][Full Text] [Related]
4. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing - treatment protocol and preliminary results.
Höfel L; Eppler B; Storf M; Schnöbel-Müller E; Haas JP; Hügle B
Pediatr Rheumatol Online J; 2018 Feb; 16(1):11. PubMed ID: 29433504
[TBL] [Abstract][Full Text] [Related]
6. 677TT genotype is associated with elevated risk of methotrexate (MTX) toxicity in juvenile idiopathic arthritis: treatment outcome, erythrocyte concentrations of MTX and folates, and MTHFR polymorphisms.
Tuková J; Chládek J; Hroch M; Nemcová D; Hoza J; Dolezalová P
J Rheumatol; 2010 Oct; 37(10):2180-6. PubMed ID: 20595278
[TBL] [Abstract][Full Text] [Related]
7. Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis.
Chen Y; Zou K; Sun J; Yang Y; Liu G
Pharmacogenomics; 2018 Apr; 19(6):529-538. PubMed ID: 29589488
[TBL] [Abstract][Full Text] [Related]
8. Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
Kyvsgaard N; Mikkelsen TS; Thastum M; Christensen AE; Wehner PS; Nysom K; Herlin T
PLoS One; 2019; 14(7):e0219539. PubMed ID: 31295288
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis.
Kyvsgaard N; Mikkelsen TS; Als TD; Christensen AE; Corydon TJ; Herlin T
Pediatr Rheumatol Online J; 2021 Apr; 19(1):51. PubMed ID: 33794950
[TBL] [Abstract][Full Text] [Related]
10. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
Aggarwal P; Naik S; Mishra KP; Aggarwal A; Misra R
Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
[TBL] [Abstract][Full Text] [Related]
11. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
van Dijkhuizen EH; Wulffraat NM
Pediatr Rheumatol Online J; 2014; 12():51. PubMed ID: 25525416
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients.
Taraborelli M; Andreoli L; Archetti S; Ferrari M; Cattaneo R; Tincani A
Clin Exp Rheumatol; 2009; 27(3):499-502. PubMed ID: 19604445
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.
Plaza-Plaza JC; Aguilera M; Cañadas-Garre M; Chemello C; González-Utrilla A; Faus Dader MJ; Calleja MA
OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111
[TBL] [Abstract][Full Text] [Related]
14. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
[TBL] [Abstract][Full Text] [Related]
15. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P
Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536
[TBL] [Abstract][Full Text] [Related]
17. Countermeasures against methotrexate intolerance in juvenile idiopathic arthritis instituted by parents show no effect.
Scheuern A; Tyrrell PN; Haas JP; Hügle B
Rheumatology (Oxford); 2017 Jun; 56(6):901-906. PubMed ID: 28122960
[TBL] [Abstract][Full Text] [Related]
18. The role of liver transaminase levels in methotrexate intolerance in juvenile idiopathic arthritis-a cross-sectional study.
Wibrand C; Kyvsgaard N; Christensen AE; Herlin T
Rheumatol Int; 2023 May; 43(5):875-880. PubMed ID: 36922416
[TBL] [Abstract][Full Text] [Related]
19. Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients.
Saleh MM; Irshaid YM; Mustafa KN
Int J Clin Pharmacol Ther; 2015 Feb; 53(2):154-62. PubMed ID: 25492850
[TBL] [Abstract][Full Text] [Related]
20. The pharmacogenetics of methotrexate in inflammatory bowel disease.
Herrlinger KR; Cummings JR; Barnardo MC; Schwab M; Ahmad T; Jewell DP
Pharmacogenet Genomics; 2005 Oct; 15(10):705-11. PubMed ID: 16141796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]